Research / LEDS / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-22-012621 General Corporate
Debt relative to revenue 38th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.debt_to_revenue
402.41% · OPTIONAL · VALID
Capex intensity 25th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.12% · OPTIONAL · VALID
Operating cash generation 13th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-46.64% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
23.98% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 50th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
229.54% · OPTIONAL · VALID
Gross margin 25th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.gross_margin
18.83% · CORE · VALID
Operating margin 50th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.operating_margin
-43.39% · CORE · VALID
R&D intensity 13th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
20.01% · OPTIONAL · VALID
SBC intensity 100th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
7.40% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 25 states Self-history eligible
Aug 31, 2021 0/9 normalized Level 3 Nov 30, 2021 0/9 normalized Level 3 Feb 28, 2022 0/9 normalized Level 3 May 31, 2022 8/9 normalized Level 3 Aug 31, 2022 8/9 normalized Level 3 Nov 30, 2022 8/9 normalized Level 3 Feb 28, 2023 8/9 normalized Level 3 May 31, 2023 9/9 normalized Level 3 Aug 31, 2023 9/9 normalized Level 3 Nov 30, 2023 9/9 normalized Level 3 Feb 29, 2024 9/9 normalized Level 3 May 31, 2024 9/9 normalized Level 3 Aug 31, 2024 9/9 normalized Level 3 Nov 30, 2024 9/9 normalized Level 3 Feb 28, 2025 9/9 normalized Level 3 May 31, 2025 9/9 normalized Level 3 Aug 31, 2025 9/9 normalized Level 3 Nov 30, 2025 9/9 normalized Level 3 Feb 28, 2026 9/9 normalized Level 3 May 31, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 339.98%
Current 402.41%
Delta 62.43% Capex Intensity Increased
Previous 0.83%
Current 1.12%
Delta 0.29% Cash Generation Decreased
Previous -19.49%
Current -46.64%
Delta -27.15% Growth Decreased
Previous 80.43%
Current 23.98%
Delta -56.46% Inventory Pressure Increased
Previous 199.03%
Current 229.54%
Delta 30.51% Margin Decreased
Previous 24.03%
Current 18.83%
Delta -5.20% Profitability Decreased
Previous -17.42%
Current -43.39%
Delta -25.97% R And D Intensity Increased
Previous 13.56%
Current 20.01%
Delta 6.45% Sbc Intensity Increased
Previous 7.08%
Current 7.40%
Delta 0.32% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.